Top Markets
#1 Velas Velas +367.72%
#2 Gravity Gravity +48.70%
#3 Galxe Galxe +41.28%
#4 Infinity Ground Infinity Ground +30.80%
#5 Wiki Cat Wiki Cat +26.84%
#6 Audiera Audiera +26.57%
#7 Fetch.ai Fetch.ai +26.24%
#8 Derive Derive +24.86%
#9 Aria.AI Aria.AI +20.75%
#10 Babylon Babylon +18.83%
Coin of the day
Velas Velas
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rang in aandelen #96
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aandeelprijs
$38.41
Marktkapitalisatie
$170.67B
Verandering (1 dag)
1.17%
Verandering (1 jaar)
-49.92%
Land
DK
Handel Novo Nordisk A/S (NVO)

Categorie

Healthcare
Marktkapitalisatie
Omzet
meer
Winst
Koersgeschiedenis
P/E-verhouding
P/S-verhouding
P/B-verhouding
Operationele marge
WPA
Aandelsplitsingen
Dividenden
Dividendrendement
Uitstaande aandelen
Aandelsplitsingen voor Novo Nordisk A/S (NVO)
Het aandeel Novo Nordisk A/S (symbool: NVO) heeft in totaal 3 splitsingen ondergaan.
De meest recente splitsing vond plaats op Sep 13, 2023.
Eén aandeel NVO dat vóór Jan 25, 2008 werd gekocht, staat nu gelijk aan 20 aandelen NVO.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2023-09-13 2:1 x2 x20
2014-01-02 5:1 x5 x10
2008-01-25 2:1 x2 x2
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 0 -
US
UCB SA UCB SA
UCB SA
UCB.BR
 0 -
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL